• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550275-18
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Myocardial Infarction (1969); Thrombosis/Thrombus (4440)
Event Date 10/29/2021
Event Type  Injury  
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The reported patient effects of myocardial infarction and thrombosis are listed in the xience sierra, everolimus eluting coronary stent system (eecss), electronic instructions for use (eifu) as known patient effects of coronary stenting procedures.The investigation determined the reported patient-device incompatibility/difficult to deploy (wall apposition) and the subsequent treatment appears to be related to the operational context of the procedure; however, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.The additional xience sierra stent referenced is being filed under a separate medwatch report number.Na.
 
Event Description
It was reported that the procedure was to treat the (b)(6) stenosed, moderately calcified, moderately tortuous mid left anterior descending (lad) coronary artery.On (b)(6) 2021, a 2.5x38 mm and a 2.75x18 mm xience sierra stent were implanted.On (b)(6) 2021, the patient returned due to st elevated myocardial infarction (stemi) and then optical coherence tomography (oct) was performed.This revealed that the stents were under expanded and malapposed as the physician did not adequately post dilate the overlap of the stents.Additionally there was in-stent thrombosis.Thrombectomy was performed and post dilatation was performed with a 3.25x15 mm nc trek balloon.Oct was again performed and showed (b)(6) of expansion in the vessel and well apposed stent struts.There were no reported adverse patient sequela.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The reported patient effects of myocardial infarction and thrombosis are listed in the xience sierra, everolimus eluting coronary stent system (eecss), electronic instructions for use (eifu) as known patient effects of coronary stenting procedures.The investigation determined the reported patient-device incompatibility/difficult to deploy (wall apposition) and the subsequent treatment appears to be related to the operational context of the procedure; however, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.The additional xience sierra stent referenced is being filed under a separate medwatch report number.Na.
 
Event Description
It was reported that the procedure was to treat the 99% stenosed, moderately calcified, moderately tortuous mid left anterior descending (lad) coronary artery.On (b)(6) 2021, a 2.5x38 mm and a 2.75x18 mm xience sierra stent were implanted.On (b)(6) 2021, the patient returned due to st elevated myocardial infarction (stemi) and then optical coherence tomography (oct) was performed.This revealed that the stents were under expanded and malapposed as the physician did not adequately post dilate the overlap of the stents.Additionally there was in-stent thrombosis.Thrombectomy was performed and post dilatation was performed with a 3.25x15 mm nc trek balloon.Oct was again performed and showed (b)(6) of expansion in the vessel and well apposed stent struts.There were no reported adverse patient sequela.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key12814140
MDR Text Key285174885
Report Number2024168-2021-10352
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648227189
UDI-Public08717648227189
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/15/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/23/2022
Device Model Number1550275-18
Device Catalogue Number1550275-18
Device Lot Number1021741
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/29/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/24/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
2.5X38 MM XIENCE SIERRA STENT.
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age56 YR
Patient SexFemale
Patient Weight81 KG
Patient EthnicityHispanic
Patient RaceWhite
-
-